• 11915 - Lambert
    Deucravacitinib, an Oral, Selective Tyrosine Kinase 2 Inhibitor, Versus Placebo and Apremilast in Moderate to Severe Plaque Psoriasis: Analysis of Body Surface Area Involvement in the Phase 3 POETYK PSO-1 and PSO-2 Trials
    Jo Lambert, Carle Paul, Alice B Gottlieb, Yves Poulin, Diamant Thaçi, Stephen Tyring, Chien-Hui Hong, Lauren Hippeli, Renata M Kisa, Lluís Puig
    Abstract

  • 11822 - Lambert
    Deucravacitinib, an oral, selective tyrosine kinase 2 inhibitor, versus placebo and apremilast in moderate to severe plaque psoriasis: analysis of body surface area involvement in the phase 3 POETYK PSO-1 and PSO-2 trials
    Jo Lambert, Carle Paul, Alice B Gottlieb, Yves Poulin, Diamant Thaçi, Stephen Tyring, Chien-Hui Hong, Lauren Hippeli, Renata M Kisa, Lluís Puig
    Poster Abstract

  • 11850 - Langley
    Long-term improvements in disease severity, itch, and quality of life after 3 years of tralokinumab treatment in adults with moderate-to-severe atopic dermatitis
    Richard Langley, Kristian Reich, Eric Simpson, Richard B Warren, Antonio Costanzo, Hidehisa Saeki, Stine Fangel, Nathan Lassota, Anna Carlsson, Melinda Gooderham, Jean Philippe Lacour, Juan Francisco Silvestre, Andreas Pinter, Andrew Blauvelt
    Poster Abstract

  • 11825 - Lim
    Impact of Visible Light on Skin Health: Role of Antioxidants and Free Radical Quenchers in Skin Protection
    Henry W. Lim, MD, Indermeet Kohli, PhD, Eduardo Ruvolo, MS, Ludger Kolbe, PhD, Iltefat Hamzavi, MD
    Poster Abstract

  • 11848 - Lipner
    Onychomycosis Dermatophytoma Treatment: A Systematic Review of the Literature
    Shari R Lipner, MD, PhD; Tracey C Vlahovic, DPM; Boni Elewski, MD; Mahmoud Ghannoum, PhD; Warren S Joseph, DPM
    Poster Abstract

  • 11843 - Ludzik
    Clinical Utility and a Guide for Using Gene Expression Profile Ancillary Diagnostic Testing for Cutaneous Melanocytic Neoplasms
    Joanna Ludzik, MD, PhD, Alexander Witkowski, MD, PhD, Brooke H Russell, PhD, Jason H Rogers, MSc, Matthew S Goldberg, MD, Abel D Jarell, MD, and Aaron S Farberg, MD
    Poster Abstract

  • 11923 - Lyons
    Pemetrexed-induced erythema and edema: a case series exploring this diagnostic dilemma
    Alexis Lyons MD, Luke Horton MD, Michael Kwa MD, Marsha Chaffins MD, & Jesse Veenstra MD
    Poster Abstract

  • 11862 - Mesinkovska
    The Invisible Impact of a Visible Disease: Psychosocial Impact of Alopecia Areata
    Natasha Mesinkovska, Brittany Craiglow, Susan Ball, Paula Morrow, Sarah G. Smith, Evangeline Pierce, Jerry Shapiro
    Poster Abstract

  • 11860 - Pinter
    Baseline Characteristics and Week 12 Modified Nail Psoriasis Severity Index Results in Patients with Moderate-to-Severe Plaque Psoriasis Treated with Biologics in the Psoriasis Study of Health Outcomes (PSoHO)
    Andreas Pinter, Saxon D. Smith, Knut Schäkel, Adam Reich, Catherine Reed, Alan Brnabic, Julie Hill, Christopher Schuster, Elisabeth Riedl, Charles Lynde
    Poster Abstract

  • 11830 - Reynolds
    Misalignment between nurse practitioners and physician assistants and their adult atopic dermatitis patients on severity, disease progression and satisfaction: results of a real-world study in the United States
    Reynolds M, Dawson Z, Malatestinic W, Anderson P, Marwaha S, Pierce E, Atwater AR, Piercy J, Aldredge L
    Poster Abstract

  • 11826 - Rigel
    Photoprotection for All: Current Gaps and Opportunities
    Darrell Rigel, MD, Henry W. Lim, MD, Zoe Draelos, MD, Teresa M. Weber, PhD, Susan Taylor, MD
    Poster Abstract

  • 11824 - Ruvolo
    Erythema and Pigmentation Protective Evaluation of Antioxidants Blends Against Visible Light and Long Wavelength UVA1
    Eduardo Ruvolo, Wyatt Boothby-Shoemaker, Nishant Kumar, Iltefat H Hamzavi, Henry W Lim, Indermeet Kohli
    Poster Abstract

  • 11865 - Schlesinger
    IMPACT OF PRIOR TREATMENT IN THE EFFICACY AND TOLERABILITY OF TIRBANIBULINOINTMENT 1% FOR ACTINIC KERATOSIS: POOLED RESULTS FROM TWO PHASE 3 STUDIES
    Todd Schlesinger, Neal Bhatia, Brian Berman, Ayman Grada, Laura Padullés, Francisco Hernández, David Cutler, Mark Lebwohl
    Poster Abstract

  • 11861 - Senna
    Baricitinib Results in Eyebrow and Eyelash Growth in Patients with Alopecia Areata Who Do Not Achieve 20% or Less Scalp Hair Loss
    Maryanne M. Senna, Ohsang Kwon, Bianca Maria Piraccini, Rodney Sinclair, Susan Ball, Yuxin Ding, Yun-Fei Chen, Yves Dutronc, Brett King
    Poster Abstract

  • 11844 - Simpson
    Effects of Ruxolitinib Cream on Pruritus and Sleep in Atopic Dermatitis: 52-Week Pooled Results From Two Phase 3 Studies
    Eric L. Simpson, MD, MCR, Mark Boguniewicz, MD, Diamant Thaçi, MD, Laurent Misery, MD, April W. Armstrong, MD, MPH, May E. Venturanza, MD, Howard Kallender, PhD, Jessy Gao, MA, Jacek C. Szepietowski, MD, PhD, FRCP (Edin)
    Poster Abstract

  • 11852 - Simpson
    Clinically meaningful responses achieved with tralokinumab in adults with moderate-to-severe atopic dermatitis who did not meet IGA 0/1 at initial 16-week treatment
    Eric Simpson, Andrew Blauvelt, Jonathan I Silverberg, Michael Cork, Norito Katoh, Thomas Mark, Ann-Marie Tindberg, Shannon Schneider, Andreas Wollenberg
    Poster Abstract

  • 11909 - Soong
    Safety of Long-Term Dupilumab Treatment in Adults With Moderate-to-Severe Atopic Dermatitis: Results from an Open-Label Extension (OLE) Trial Up to 4 Years
    Weily Soong, Melinda Goooderham, Robert Bissonnette, Andreas Wollenberg, Jing Xiao, Faisal A. Khokhar, Ainara Rodríguez Marco, Noah A. Levit, Arsalan Shabbir
    Poster Abstract

  • 11903 - Strober
    Bimekizumab maintenance of response through three years in patients with moderate to severe plaque psoriasis who responded at Week 16: Results from the BE BRIGHT open-label extension trial
    Bruce Strober, Yayoi Tada, Ulrich Mrowietz, Mark Lebwohl, Peter Foley, Richard G. Langley, Jonathan Barker, Maggie Wang, Veerle Vanvoorden, Balint Szilagyi, Valerie Ciaravino, Carle Paul
    Abstract

  • 11835 - Strober
    Bimekizumab maintenance of response through three years in patients with moderate to severe plaque psoriasis who responded at Week 16: Results from the BE BRIGHT open-label extension trial
    Bruce Strober, Yayoi Tada, Ulrich Mrowietz, Mark Lebwohl, Peter Foley, Richard G. Langley, Jonathan Barker, Maggie Wang, Veerle Vanvoorden, Balint Szilagyi, Valerie Ciaravino, Carle Paul
    Poster

  • 11828 - Taylor
    Photoprotection for Skin of All Color: Consensus and Clinical Guidance From An Expert Panel
    Susan C. Taylor, MD, Henry W. Lim, MD, Andrew F. Alexis, MD, MPH, April W. Armstrong, MD, MPH, Zelma C. Chiesa Fuxench, MD, MSCE, Zoe Draelos, MD, Iltefat Hamzavi, MD, Darrell Rigel, MD, MS
    Poster Abstract